Hoya Corp
TSE:7741
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its 3-Year Average (34.3), the stock would be worth ¥25 385.51 (9% downside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 37.6 | ¥27 830 |
0%
|
| 3-Year Average | 34.3 | ¥25 385.51 |
-9%
|
| 5-Year Average | 34.9 | ¥25 870 |
-7%
|
| Industry Average | 20.7 | ¥15 359.68 |
-45%
|
| Country Average | 17 | ¥12 598.91 |
-55%
|
Forward P/E
Today’s price vs future net income
| Today's Market Cap | Net Income | Forward P/E | ||
|---|---|---|---|---|
|
¥9.8T
|
/ |
Jan 2026
¥250.4B
|
= |
|
|
¥9.8T
|
/ |
Mar 2026
¥250.4B
|
= |
|
|
¥9.8T
|
/ |
Mar 2027
¥268.5B
|
= |
|
|
¥9.8T
|
/ |
Mar 2028
¥304.7B
|
= |
|
Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| JP |
|
Hoya Corp
TSE:7741
|
9.4T JPY | 37.6 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
58.4B USD | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
28.4B CHF | 36.3 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
88.8B DKK | 22.7 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.6B USD | 30.6 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.1T KRW | -36.5 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.1B GBP | 31.2 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
37.9B CNY | 23 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
37.3B CNY | 21.9 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
861.2B JPY | 48.7 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.6B USD | -15.6 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.1 |
| Median | 17 |
| 70th Percentile | 23 |
| Max | 7 956 708 |
Other Multiples
Hoya Corp
Glance View
In the bustling corridors of Tokyo, Hoya Corporation has woven a remarkable narrative since its inception in 1941. Originally founded as a specialty glass manufacturer, Hoya has deftly navigated the shifting tides of technological advancement, transforming itself into a multifaceted entity deeply embedded in the optics and technology sectors. Today, Hoya stands as a pioneer in the production of optical lenses, endoscopy systems, and sophisticated glass substrates essential for hard disk drives. The firm has strategically capitalized on the ever-growing demand in both healthcare and electronics, making a mark with its lens segment, which caters to both eyeglass wearers and the burgeoning field of medical technology. Underpinned by a philosophy of innovation and diversified growth, Hoya has continually bolstered its portfolio through strategic acquisitions and robust research and development initiatives. The company deftly harnesses its expertise in precision glass to deliver critical components such as semiconductor mask blanks, demonstrating its pivotal role in the digital economy's supply chain. This confluence of cutting-edge technology and strategic foresight not only underlines Hoya's financial vitality but also cements its crucial position in an array of global markets, from consumer optics to intricate healthcare solutions. In weaving these threads through its business fabric, Hoya not only sustains a legacy of over eight decades but also fortifies its trajectory for future expansion, driven by continuous innovation and a keen sense for market evolution.